30 Results for "

chronic constipation

" in MedChemExpress (MCE) Product Catalog:
Products (30)

30 Results for "chronic constipation" in MCE Product Catalog:

5
5 Cited Publications
Art. -Nr.: HY-17638
CAS. Nr.: 666843-10-3
Synonyms: DSP-3235 free base; KGA-3235 free base; GSK-1614235 free base
Target:  

SGLT

Forschungsgebiete:  

Metabolic Disease

Mizagliflozin (DSP-3235 free base) is a potent, orally active and selective SGLT1 inhibitor, with a Ki of 27 nM for human SGLT1. Mizagliflozin displays 303-fold selectivity over SGLT2. Mizagliflozin is used as an antidiabetic agent that can modify postprandial blood glucose excursion. Mizagliflozin also exhibits potential in the amelioration of chronic constipation .
loading...
    loading...
4
4 Cited Publications
Art. -Nr.: HY-14151
CAS. Nr.: 179474-81-8
Reinheit:  99.81%
Forschungsgebiete:  

Neurological Disease Cancer

Prucalopride is an orally active, selective and specific 5-HT 4 receptor agonist (high affinity), with pKis of 8.6 and 8.1 for human 5-HT4a/4b receptors, respectively. Prucalopride improves intestinal motility by promoting regeneration of the intestinal nervous system in rats. Prucalopride also shows anticancer activity by blocking of the PI3K/AKT/mTor signaling pathway. Prucalopride can be used in studies of chronic constipation, pseudo-intestinal obstruction and cancer .
loading...
    loading...
4
4 Cited Publications
Art. -Nr.: HY-12694
CAS. Nr.: 179474-85-2
Reinheit:  99.95%
Synonyms: R-108512
Forschungsgebiete:  

Metabolic Disease Cancer

Prucalopride succinate is an orally active, selective and specific 5-HT 4 receptor agonist (high affinity), with pKis of 8.6 and 8.1 for human 5-HT4a/4b receptors, respectively. Prucalopride succinate improves intestinal motility by promoting regeneration of the intestinal nervous system in rats. Prucalopride succinate also shows anticancer activity by blocking of the PI3K/AKT/mTor signaling pathway. Prucalopride succinate can be used in studies of chronic constipation, pseudo-intestinal obstruction and cancer .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-17584
CAS. Nr.: 851199-59-2
Target:  

Guanylate Cyclase

Forschungsgebiete:  

Cancer

Linaclotide is a potent and selective guanylate cyclase C agonist; developed for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation.
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-17584A
CAS. Nr.: 851199-60-5
Target:  

Guanylate Cyclase

Forschungsgebiete:  

Cancer

Linaclotide acetate is a potent and selective guanylate cyclase C agonist; developed for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation.
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-B0679
CAS. Nr.: 136790-76-6
Synonyms: RU-0211; SPI-0211
Lubiprostone (SPI-0211) increases intestinal fluid secretion through generation of CIC-2/CFTR and activation of cAMP signaling pathway. Lubiprostone inhibits myeloperoxidase (MPO) activity, downregulates Indomethacin (HY-14397)-induced iNOS and TNFα expression. Lubiprostone can be used for chronic constipation research .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-15790
CAS. Nr.: 439087-18-0
Reinheit:  99.91%
Synonyms: A 3309; AZD 7806
Elobixibat (A 3309; AZD 7806) is an orally active, bile acid transporter (IBAT) inhibitor with IC50 values ??of 0.53 nM (human IBAT), 0.13 nM (mouse IBAT), and 5.8 nM (canine IBAT). Elobixibat can lower LDL cholesterol, increase serum GLP-1, promote colonic motility, and has the potential to study metabolic syndrome. Elobixibat can be used in the study of chronic functional constipation (CIC), dyslipidemia, non-alcoholic hepatitis, and liver tumors in the elderly .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-15790A
CAS. Nr.: 1633824-78-8
Reinheit:  99.44%
Synonyms: A 3309 hydrate; AZD 7806 hydrate
Elobixibat (A 3309; AZD 7806) hydrate is an orally active, bile acid transporter (IBAT) inhibitor with IC50 values ??of 0.53 nM (human IBAT), 0.13 nM (mouse IBAT), and 5.8 nM (canine IBAT). Elobixibat hydrate can lower LDL cholesterol, increase serum GLP-1, promote colonic motility, and has the potential to study metabolic syndrome. Elobixibat hydrate can be used in the study of chronic functional constipation (CIC), dyslipidemia, non-alcoholic hepatitis, and liver tumors in the elderly .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-144401
CAS. Nr.: 1369412-66-7
Reinheit:  99.18%
Target:  

Motilin Receptor

Forschungsgebiete:  

Metabolic Disease

DS-3801b is a potent and non-macrolide agonist of GPR38. DS-3801b is expected to be novel gastrointestinal prokinetic agents for the research of functional gastrointestinal disorders such as gastroparesis and chronic constipation .
loading...
    loading...
Art. -Nr.: HY-108741
CAS. Nr.: 467426-54-6
Reinheit:  99.93%
Target:  

Guanylate Cyclase

Forschungsgebiete:  

Inflammation/Immunology Cancer

Plecanatide, an analogue of Uroguanylin, is an orally active guanylate cyclase-C (GC-C) receptor agonist. Plecanatide activates GC-C receptors to stimulate cGMP synthesis with an EC50 of 190 nM in T84 cells assay. Plecanatide shows anti-inflammatory activity in models of murine colitis .
loading...
    loading...
Art. -Nr.: HY-N7104
CAS. Nr.: 585-86-4
Synonyms: D-Lactitol
Target:  

Bacterial

Lactitol (D-Lactitol) is a non-absorbable disaccharide and Bacterial regulator. Lactitol reduces the populations of Bacteroides, Clostridium, coliforms and Eubacterium, while increasing the populations of Lactobacillus and Streptococcus. Lactitol can be used in the research of portosystemic encephalopathy and chronic constipation .
loading...
    loading...
Art. -Nr.: HY-B1389
CAS. Nr.: 81025-04-9
Synonyms: D-Lactitol monohydrate
Target:  

Bacterial

Lactitol monohydrate (D-Lactitol monohydrate) is a non-absorbable disaccharide and Bacterial regulator. Lactitol monohydrate reduces the populations of Bacteroides, Clostridium, coliforms and Eubacterium, while increasing the populations of Lactobacillus and Streptococcus. Lactitol monohydrate can be used in the research of portosystemic encephalopathy and chronic constipation .
loading...
    loading...
Art. -Nr.: HY-107929
CAS. Nr.: 37286-92-3
Synonyms: Poly(styrenesulfonic acid) calcium salt
Target:  

Potassium Channel

Forschungsgebiete:  

Metabolic Disease

Calcium polystyrene sulfonate (Poly(styrenesulfonic acid) calcium salt) is an orally active potassium-lowering agent. Calcium polystyrene sulfonate binds potassium in the distal colon in exchange for Ca 2+. Calcium polystyrene sulfonate can be used for the research of hyperkalemia in chronic kidney disease .
loading...
    loading...
Art. -Nr.: HY-108741A
CAS. Nr.: 1075732-84-1
Reinheit:  99.51%
Target:  

Guanylate Cyclase

Forschungsgebiete:  

Inflammation/Immunology Cancer

Plecanatide acetate, an analogue of Uroguanylin, is an orally active guanylate cyclase-C (GC-C) receptor agonist. Plecanatide acetate activates GC-C receptors to stimulate cGMP synthesis with an EC50 of 190 nM in T84 cells assay. Plecanatide acetate can be used for the research of chronic idiopathic constipation, and it also shows anti-inflammatory activity in models of murine colitis .
loading...
    loading...
Art. -Nr.: HY-121826
CAS. Nr.: 860174-12-5
Synonyms: ATI-7505
Target:  

5-HT Receptor

Naronapride (ATI-7505) is a potent prokinetic 5-HT4 receptor agonist. Naronapride can be used for gastrointestinal diseases research .
loading...
    loading...
Art. -Nr.: HY-B0680
CAS. Nr.: 333963-40-9
Synonyms: RU-0211 (hemiketal); SPI-0211 (hemiketal)
Target:  

Chloride Channel

Forschungsgebiete:  

Others Cancer

Lubiprostone (hemiketal) (RU-0211 (hemiketal)) is a selective chloride channel 2 (CLCN2) activator. Lubiprostone (hemiketal) is used to treat chronic idiopathic constipation and opioid-induced constipation by activating CLCN2 channels to increase chloride ion secretion in the intestine, thereby increasing intestinal fluid secretion and enhancing intestinal peristalsis. Lubiprostone (hemiketal) can be used in the study of chronic constipation and cancer .
loading...
    loading...
Art. -Nr.: HY-17584R
CAS. Nr.: 851199-59-2
Forschungsgebiete:  

Cancer

Linaclotide (Standard) is the analytical standard of Linaclotide. This product is intended for research and analytical applications. Linaclotide is a potent and selective guanylate cyclase C agonist; developed for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation.
loading...
    loading...
Art. -Nr.: HY-15790H
CAS. Nr.: 439087-68-0
Synonyms: (S)-A 3309; (S)-AZD 7806
(S)-Elobixibat is the S enantiomer of Elobixibat (HY-15790). (S)-Elobixibat is an orally effective Apical Sodium-Dependent Bile (IBAT) inhibitor. (S)-Elobixibat decreases LDL cholesterol, increases serum GLP-1, promotes colon motility, and has the potential to study metabolic syndrome. (S)-Elobixibat can be used to study constipation, dyslipidemia, non-alcoholic hepatitis, and liver tumors .
loading...
    loading...
Art. -Nr.: HY-12694R
CAS. Nr.: 179474-85-2
Synonyms: R-108512 (Standard)
Prucalopride (succinate) (Standard) is the analytical standard of Prucalopride (succinate). This product is intended for research and analytical applications. Prucalopride succinate is an orally active, selective and specific 5-HT 4 receptor agonist (high affinity), with pKis of 8.6 and 8.1 for human 5-HT4a/4b receptors, respectively. Prucalopride succinate improves intestinal motility by promoting regeneration of the intestinal nervous system in rats. Prucalopride succinate also shows anticancer activity by blocking of the PI3K/AKT/mTor signaling pathway. Prucalopride succinate can be used in studies of chronic constipation, pseudo-intestinal obstruction and cancer .
loading...
    loading...
Art. -Nr.: HY-P11246
CAS. Nr.: 3057097-31-8
Target:  

RXFP Receptor

Forschungsgebiete:  

Metabolic Disease

A13:B7-24-GG is an engineered analogue of insulin-like peptide 5 (INSL5), a selective RXFP4 agonist with a Ki value of 2.29 nM. A13:B7-24-GG has an extremely low binding affinity for RXFP3 (Ki = 602.56 nM) and an inhibitory effect on cAMP (EC50) of 1.17 nM. Activation of RXFP4 by A13:B7-24-GG leads to the recruitment of β-Arrestin2, with an EC50 of 22.39 nM. A13:B7-24-GG can be used for research on chronic constipation .
loading...
    loading...